FOLD FY 2011 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+2224.7% YoY

Gross Profit

$21M100.0% margin

Operating Income

-$51M-237.4% margin

Net Income

-$44M-207.2% margin

EPS (Diluted)

$-1.28

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$51M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$70M

Total Liabilities

$40M

Stockholders' Equity

$30M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$922,000	+2224.7%
Gross Profit	$21M	$922,000	+2224.7%
Operating Income	-$51M	-$56M	+8.9%
Net Income	-$44M	-$55M	+19.2%